Hormonal receptor positive breast cancer adjuvant and metastatic indications
Holger Stenzhorn discusses his involvement with the Personalized Medicine project to develop software for clinical trials. He explains the benefits to doctors and patients, collecting feedback to ensure that it's successful and what's next for the future.
Read our Special Issue on the Personalized Medicine project.
Hormonal receptor positive breast cancer adjuvant and metastatic indications
ASCO 2024: Lung cancer highlights
Quality of life and patient satisfaction of Filipinos after breast conservation surgery and intraoperative radiotherapy
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Multiple myeloma in a resource constrained setting
Synthetic biology and precision medicine in blood and gynaecological cancers
Early-stage breast cancer detection in breast milk
The TARGIT-A randomised trial: TARGIT-IORT versus whole breast radiation therapy: long-term local control and survival
Moving to the future: Artificial intelligence in surgery